The high prevalence of polypharmacy and potentially inappropriate medications in the elderly makes them a vulnerable group to adverse drug events. Deprescribing is the medication review plus cessation of potentially inappropriate medications with a health professional’s help. Several barriers and enablers influence it, and its knowledge can help health professionals. The objective of the study is to understand the Portuguese elderly’s attitudes and ideas about polypharmacy and deprescription. We made a qualitative approach through a focus group with elderly patients from an adult daycare center with transcription and codification into themes and subthemes based on previous frameworks. Eleven elderly patients participated in the focus group....
Background: Elderly patients with multimorbidity who are treated according to guidelines use a large...
BACKGROUND: General practitioners (GPs) should regularly review patients' medications and, if necess...
BACKGROUND Many oldest-old (> 80-years) with multimorbidity and polypharmacy are at high risk of ...
The ageing population has resulted in an increase in multimorbidity and polypharmacy, and subsequent...
BACKGROUND Multimorbidity and polypharmacy are very common in older adults in primary care. Ideal...
Summary: Background: Elderly are mostly affected by polypharmacy induced adverse drug events as the...
INTRODUCTION Multimorbidity and polypharmacy are current challenges when caring for the older pop...
BACKGROUND Polypharmacy is an increasing problem, leading to increased morbidity and mortality, e...
BackgroundMultimorbidity and polypharmacy are very common in older adults in primary care. Ideally, ...
IntroductionMultimorbidity and polypharmacy are current challenges when caring for the older populat...
peer reviewed[en] INTRODUCTION: To reduce inappropriate polypharmacy, deprescribing should be part o...
BACKGROUND Polypharmacy is an increasing problem, leading to increased morbidity and mortality, esp...
Background: Multimorbidity and polypharmacy are very common in older adults in primary care. Ideally...
The increase in the number of medications used may result many negative consequences for patients an...
Background Deprescribing has been recommended for managing polypharmacy but deprescribing preventive...
Background: Elderly patients with multimorbidity who are treated according to guidelines use a large...
BACKGROUND: General practitioners (GPs) should regularly review patients' medications and, if necess...
BACKGROUND Many oldest-old (> 80-years) with multimorbidity and polypharmacy are at high risk of ...
The ageing population has resulted in an increase in multimorbidity and polypharmacy, and subsequent...
BACKGROUND Multimorbidity and polypharmacy are very common in older adults in primary care. Ideal...
Summary: Background: Elderly are mostly affected by polypharmacy induced adverse drug events as the...
INTRODUCTION Multimorbidity and polypharmacy are current challenges when caring for the older pop...
BACKGROUND Polypharmacy is an increasing problem, leading to increased morbidity and mortality, e...
BackgroundMultimorbidity and polypharmacy are very common in older adults in primary care. Ideally, ...
IntroductionMultimorbidity and polypharmacy are current challenges when caring for the older populat...
peer reviewed[en] INTRODUCTION: To reduce inappropriate polypharmacy, deprescribing should be part o...
BACKGROUND Polypharmacy is an increasing problem, leading to increased morbidity and mortality, esp...
Background: Multimorbidity and polypharmacy are very common in older adults in primary care. Ideally...
The increase in the number of medications used may result many negative consequences for patients an...
Background Deprescribing has been recommended for managing polypharmacy but deprescribing preventive...
Background: Elderly patients with multimorbidity who are treated according to guidelines use a large...
BACKGROUND: General practitioners (GPs) should regularly review patients' medications and, if necess...
BACKGROUND Many oldest-old (> 80-years) with multimorbidity and polypharmacy are at high risk of ...